Singapore Extends Fee-Free Patent Examination Deadline Pilot to 2027

The Intellectual Property Office of Singapore (IPOS) introduced a pilot through Patents Circular No. 4/2024 on 19 August 2024 allowing eligible applicants to obtain up to 18 months of additional time to request a search and/or examination report without paying the official extension-of-time fee. IPOS then extended the pilot for another year through Circular No. 4/2026 dated 12 August 2026. The current window covers relevant prescribed deadlines falling between 1 September 2024 and 31 August 2027.

The measure is more significant than a simple fee waiver. It gives applicants additional time to assess overseas prosecution results, commercial traction and portfolio priorities before committing to the next stage of Singapore examination. But the boundary matters: the waiver applies to the Patents Form 45 extension request, not to the PF11 or PF12 search and examination fees themselves, and it does not create a general suspension of all patent deadlines.

The waiver covers the extension request, not examination itself

Circular No. 4/2024 applies to specified requests under section 29 of Singapore's Patents Act, including requests for a search and examination report under section 29(1)(b) and requests for an examination report under section 29(1)(c) or section 29(3). The ordinary prescribed period for making these requests is generally 36 months. Under the pilot, eligible applicants may use Patents Form 45 under rule 108(4) to obtain up to 18 additional months.

The practical distinction is easy to miss. “No extension of time fee” does not mean “free examination.” IPOS separates the fee for obtaining more time from the substantive filing fees payable for PF11 or PF12. Those search, search-and-examination or examination fees remain payable. The policy therefore reduces the cost of buying procedural time, rather than removing the cost of examination.

The pilot also has defined limits. The 2024 circular does not extend to a standalone request for a search report under section 29(1)(a) using PF10. Applicants must select the relevant pilot option in Form 45 and meet the applicable procedural requirements. Where an earlier extension of less than 18 months has already been granted, the pilot can generally be used to bring the total extension up to 18 months; it is not an additional 18 months on top of an existing extension.

Eighteen months can change portfolio decisions

For multinational applicants, the timing of Singapore examination often sits inside a much broader prosecution calendar. At the 36-month point, an applicant may still be waiting for useful examination outcomes in the United States, Europe, China or the PCT route, or may not yet know whether the product concerned will become commercially important in Southeast Asia. A fee-free extension allows that decision to be postponed until more information is available.

That can be valuable for budget control. Early-stage portfolios frequently face multiple prosecution fees, translation costs, local counsel charges and R&D spending at the same time. The pilot lets a company move some expenditure from “must be paid now” to “can be evaluated later.” For technologies still being refined, licensing discussions that remain unsettled, or businesses approaching a financing milestone, the value of that extra decision time can exceed the amount of the waived extension fee.

Delay is not automatically the better strategy. If a granted Singapore patent is important for fundraising, tenders, licensing leverage or enforcement preparation, keeping the application pending for longer may reduce certainty. IPOS continues to offer accelerated routes such as SG Patents Fast and the Patent Prosecution Highway for applicants that need earlier results. The pilot adds optionality; it should not become a default instruction to postpone every case.

Circular No. 3/2024 and No. 4/2024 point in the same direction

Four days before Circular No. 4/2024, IPOS issued Circular No. 3/2024 to simplify certain requests for examination reports. From 16 August 2024, where an applicant relies on final search results established by IPOS in the PCT framework, the procedure was simplified so that Patents Form 12 could be filed without separately submitting the final international search results, copies of cited documents and the corresponding patent family reference list.

Read together, the two measures show a clear administrative approach: reduce duplicated paperwork on one side and give eligible applicants more time to make prosecution decisions on the other. Neither measure lowers the patentability threshold or removes substantive examination. Their effect is to reduce friction around the process so that Singapore prosecution can be managed more closely alongside global examination results and business developments.

This combination can be particularly useful for PCT users. Where IPOS has already generated usable international-stage search material, national-stage applicants may face less document duplication; if the commercial case is still developing, they may also have up to 18 months of additional time before committing to the next Singapore examination step.

After the 2026 extension, internal deadlines matter more than the outer limit

Circular No. 4/2026 extended the pilot by another year following positive stakeholder feedback. The mechanism now applies, subject to the existing conditions, where the relevant 36-month prescribed period falls between 1 September 2024 and 31 August 2027. The remaining terms of the 2024 arrangement continue to apply.

Portfolio managers should resist the temptation simply to move every eligible case 18 months to the right. A better approach is to maintain two dates: the official outer deadline and an earlier internal review date. That internal checkpoint can be tied to a first office action in a major family member, a financing round, a product launch decision or a licensing milestone. Used this way, the pilot becomes a management tool rather than a way of accumulating deferred deadlines.

There is also a procedural risk in waiting until after the prescribed period has expired. Although the pilot allows a qualifying extension request to be made after expiry, IPOS has advised applicants to file before the deadline where possible so the application is not first treated as abandoned. High-volume applicants should therefore flag potential Form 45 cases early and separately docket Form 45, PF11/PF12 and the subsequent examination steps.

The policy is most useful when it reduces premature decision-making. Treating 18 months as “free delay” misses the point. Using that time to obtain better foreign prosecution signals, commercial data or licensing feedback can produce a more disciplined Singapore filing strategy and a more efficient patent budget.